Patents by Inventor Nadezhda Glezeva

Nadezhda Glezeva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS
    Publication number: 20220033907
    Abstract: The invention provides a method of prognosing and/or diagnosing heart disease or heart failure in a subject, comprising determining the methylation status and/or expression level of at least one methylation marker selected from the group consisting of MFSD2B, miR24-1, TTPA, GALNT15, ITGBL1, SMOC2, MSR1, PVT1, MYOM3, COX17, MYBPC3, HEY2, and MRPL44 wherein the methylation status and/or expression level of at least one methylation marker is indicative of the prognosis and/or diagnosis of said subject. A panel of biomarkers, means, a kit and a device for use in assessing risk of HCM, ISCM and DCM are disclosed.
    Type: Application
    Filed: February 14, 2020
    Publication date: February 3, 2022
    Inventors: Chris Watson, Mark Ledwidge, John Baugh, Nadezhda Glezeva, Sudipto Das